Share Class
GB00BMGLBK75
A global, high-conviction equity fund for long-term investors
- A fund focusing on high quality companies with sustainable profitability, “compounders” that reinvest their earnings for future growth
- A concentrated, low turnover portfolio of high-conviction names seeking to achieve steady capital growth over the long term
Key documents
Asset Allocation
Equities93.1 %
Other6.9 %
Data as of: 29 Nov 2024.
Risk Indicator
6/7
Recommended Minimum Investment Horizon
5 years
Cumulative Performance since launch
Cumulative Performance 10 YearsCumulative Performance 5 YearsCumulative Performance 3 YearsCumulative Performance 12 Months
+ 76.2 %
0.0 %
0.0 %
+ 18.6 %
+ 22.6 %
To 29/11/2024
Calendar Year Performance 2014Calendar Year Performance 2015Calendar Year Performance 2016Calendar Year Performance 2017Calendar Year Performance 2018Calendar Year Performance 2019Calendar Year Performance 2020Calendar Year Performance 2021Calendar Year Performance 2022Calendar Year Performance 2023
-
-
-
-
-
-
+ 23.1 %
+ 22.6 %
- 19.0 %
+ 21.0 %
Net Asset Value
1.76 £
Asset Under Management
85 M £
Market
Global market
Data as of: 29 Nov 2024.
Data as of: 29 Nov 2024.
Past performance is not necessarily indicative of future performance. Performances are net of fees (excluding possible entrance fees charged by the distributor). The return may increase or decrease as a result of currency fluctuations, for the shares which are not currency-hedged.
FP Carmignac Global Equity Compounders fund performance
Take a look at the Fund's performance supported by our Fund managers’ market commentary and strategy insight.Our monthly comments
Data as of: 31 Oct 2024.Fund management team
![[Management Team] [Author] Denham Mark](https://carmignac.imgix.net/uploads/NextImage/0001/18/%5BManagement-Team%5D-Denham-Mark.png?auto=format%2Ccompress&fit=fill&w=3840)
Mark Denham
Head of Equities, Fund Manager
![[Management Team] [Author] Ejikeme Obe](https://carmignac.imgix.net/uploads/NextImage/0001/18/%5BManagement-Team%5D-Ejikeme-Obe.png?auto=format%2Ccompress&fit=fill&w=3840)
Obe Ejikeme
Fund Manager, Analyst
Performance commentary
- The fund underperformed its performance indicator over the month.- The fund suffered from the underperformance of the most defensive sectors, such as healthcare and consumer staples.- The fund was also affected by the results season, with some of our holdings being penalized.- Microsoft, the fund's largest holding, reported solid results but provided a disappointing outlook for its cloud business, which weighed on the share price. - Similarly, ASML, a position we trimmed the past few months, declined following an earnings warning, as did Thermo Fisher, which announced a drop in third-quarter sales.- On a positive note, most of our technology stocks performed well. Nvidia, which we re-increased recently, along with Ansys and Cadence Design, showed strong performance.
Outlook strategy
- Quality cyclical stocks have shown better performance in recent weeks, buoyed by optimism that growth is more resilient than expected.- In light of company results, we remain cautious and are maintaining our current positioning. We favor defensive-quality companies against the backdrop of a global economic slowdown and deteriorating corporate margins. - Consequently, we have made few changes to the portfolio this month, with only a slight increase in our exposure to technology stocks. - As a result, Nvidia has returned to the fund's top three holdings.
Performance Overview
Data as of: 19 Dec 2024.Past performance is not necessarily indicative of future performance. Performances are net of fees (excluding possible entrance fees charged by the distributor). Morningstar Rating™ : © Morningstar, Inc. All Rights Reserved. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
Source: Carmignac at 21/12/2024
FP Carmignac Global Equity Compounders Portfolio overview
Below is an overview of the composition of the portfolio.Geographical Breakdown
Data as of: 29 Nov 2024.| North America | 72.4 % |
| Europe | 27.6 % |
| Total % Equities | 100.0 % |
North America72.4 %
 USA | 72.4 % |
Key figures
Below are the key figures for the Fund, which will give you a clearer idea of the Fund's management and equity positioning.Exposure Data
Data as of: 29 Nov 2024.Equity Investment Weight93.1 %
Net Equity Exposure93.1 %
Number of Equity Issuers44
Active Share80.5 %
The strategy in a nutshell
Discover the Fund’s main features and benefits through the words of the Fund Managers.Fund Management Team
Mark Denham
Head of Equities, Fund Manager
Obe Ejikeme
Fund Manager, Analyst
In our approach to European equities, we focus on sustainable high-quality companies which demonstrate high levels of profitability while favoring profits reinvestment over profits distribution to grow the business for the future.
Did you enjoy the fund page?
Reference to certain securities and financial instruments is for illustrative purposes to highlight stocks that are or have been included in the portfolios of funds in the Carmignac range. This is not intended to promote direct investment in those instruments, nor does it constitute investment advice. The Management Company is not subject to prohibition on trading in these instruments prior to issuing any communication. The portfolios of Carmignac funds may change without previous notice.
The reference to a ranking or prize, is no guarantee of the future results of the UCIS or the manager.
The information presented above is not contractually binding and does not constitute investment advice. Past performance is not a reliable indicator of future performance. Performance is shown net of fees (excluding any subscription fees payable to the distributor). Investors may lose some or all of their capital, as the capital in the UCI is not guaranteed. Access to the products and services presented herein may be restricted for some individuals or countries. Taxation depends on the situation of the individual. The risks, fees and recommended investment period for the UCI presented are detailed in the KIDs (key information documents) and prospectuses available on this website. The KID must be made available to the subscriber prior to purchase.
The information presented above is not contractually binding and does not constitute investment advice. Past performance is not a reliable indicator of future performance. Performances are net of fees (excluding possible entrance fees charged by the distributor), where applicable. Investors may lose some or all of their capital, as the capital in the UCI is not guaranteed. Access to the products and services presented herein may be restricted for some individuals or countries. Taxation depends on the situation of the individual. The risks, fees and recommended investment period for the UCI presented are detailed in the KIDs (key information documents) and prospectuses available on this website. The KID must be made available to the subscriber prior to purchase.). The reference to a ranking or prize, is no guarantee of the future results of the UCITS or the manager.
Market environment